Relationship between Plasma Endothelin-1 and Glycemic Control in Type 2 Diabetes Mellitus
- Autores
- Sanchez, Sara Serafina del V.; Aybar, Manuel Javier; Velarde, M.S.; Prado, M.M.; Carrizo T.R.
- Año de publicación
- 2001
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The pathogenesis of the vascular complications of diabetes is controversial, micro- and macroangiopathy being the most common cause of morbidity and mortality in diabetic patients. Endothelial cell damage, thought to occur in diabetic patients, may be an important factor in development of angiopathy . For the last few years, considerable evidence has connected endothelin-1 (ET-1), a strong endothelial-derived vasoconstrictor mitogenic peptide, with various cardiovascular disease states . Plasma ET-1 concentrations were found to be abnormally high in patients with conditions associated with endothelial cell injury, as well as in those with hypertension , congestive heart failure , coronary artery disease, and uremia . Contradictory findings regarding ET-1 levels have been reported in patients suffering from diabetes mellitus . Bertello et al. and Kanno et al. described similar plasma ET-1 levels in both healthy controls and patients with non-insulin-dependent diabetes mellitus (Type 2 diabetes) with and without complications. However, the influence of Type 2 diabetes on plasma endothelin levels was definitely established in patients with advanced atherosclerosis . Recent clinical studies have indicated that the normalization of glycemic control cannot only prevent diabetic microangiopathies, but might possibly avert cardiovascular complications , thus pointing to hyperglycemia as the major causal factor in the development of diabetic vascular complications. Moreover, there are indications that high blood glucose is involved in the pathogenesis of coronary heart disease, being a significant factor in cardiovascular mortality . However, in spite of the significant effects of hyperglycemia, very few studies have dealt with the possible influence of glucose metabolic control on endothelial reactivity in Type 2 diabetic patients. The aims of the present paper were a) to establish the possible relationship between plasma ET-1 levels and Type 2 diabetes by comparing plasma ET-1 concentrations in healthy subjects with those in patients with uncomplicated Type 2 diabetes and b) to determine whether ET-1 levels were related to glucose metabolic control in diabetic patients.
Fil: Sanchez, Sara Serafina del V.. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Instituto Superior de Investigaciones Biológicas. Universidad Nacional de Tucumán. Instituto Superior de Investigaciones Biológicas; Argentina
Fil: Aybar, Manuel Javier. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Instituto Superior de Investigaciones Biológicas. Universidad Nacional de Tucumán. Instituto Superior de Investigaciones Biológicas; Argentina
Fil: Velarde, M.S.. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia; Argentina
Fil: Prado, M.M.. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia; Argentina
Fil: Carrizo T.R.. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia; Argentina - Materia
-
endothelin-1
diabetes - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/97944
Ver los metadatos del registro completo
id |
CONICETDig_e09b08e9d585624fe8337cf84991ec1d |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/97944 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Relationship between Plasma Endothelin-1 and Glycemic Control in Type 2 Diabetes MellitusSanchez, Sara Serafina del V.Aybar, Manuel JavierVelarde, M.S.Prado, M.M.Carrizo T.R.endothelin-1diabeteshttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1The pathogenesis of the vascular complications of diabetes is controversial, micro- and macroangiopathy being the most common cause of morbidity and mortality in diabetic patients. Endothelial cell damage, thought to occur in diabetic patients, may be an important factor in development of angiopathy . For the last few years, considerable evidence has connected endothelin-1 (ET-1), a strong endothelial-derived vasoconstrictor mitogenic peptide, with various cardiovascular disease states . Plasma ET-1 concentrations were found to be abnormally high in patients with conditions associated with endothelial cell injury, as well as in those with hypertension , congestive heart failure , coronary artery disease, and uremia . Contradictory findings regarding ET-1 levels have been reported in patients suffering from diabetes mellitus . Bertello et al. and Kanno et al. described similar plasma ET-1 levels in both healthy controls and patients with non-insulin-dependent diabetes mellitus (Type 2 diabetes) with and without complications. However, the influence of Type 2 diabetes on plasma endothelin levels was definitely established in patients with advanced atherosclerosis . Recent clinical studies have indicated that the normalization of glycemic control cannot only prevent diabetic microangiopathies, but might possibly avert cardiovascular complications , thus pointing to hyperglycemia as the major causal factor in the development of diabetic vascular complications. Moreover, there are indications that high blood glucose is involved in the pathogenesis of coronary heart disease, being a significant factor in cardiovascular mortality . However, in spite of the significant effects of hyperglycemia, very few studies have dealt with the possible influence of glucose metabolic control on endothelial reactivity in Type 2 diabetic patients. The aims of the present paper were a) to establish the possible relationship between plasma ET-1 levels and Type 2 diabetes by comparing plasma ET-1 concentrations in healthy subjects with those in patients with uncomplicated Type 2 diabetes and b) to determine whether ET-1 levels were related to glucose metabolic control in diabetic patients.Fil: Sanchez, Sara Serafina del V.. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Instituto Superior de Investigaciones Biológicas. Universidad Nacional de Tucumán. Instituto Superior de Investigaciones Biológicas; ArgentinaFil: Aybar, Manuel Javier. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Instituto Superior de Investigaciones Biológicas. Universidad Nacional de Tucumán. Instituto Superior de Investigaciones Biológicas; ArgentinaFil: Velarde, M.S.. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia; ArgentinaFil: Prado, M.M.. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia; ArgentinaFil: Carrizo T.R.. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia; ArgentinaGeorg Thieme Verlag Kg2001-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/97944Sanchez, Sara Serafina del V.; Aybar, Manuel Javier; Velarde, M.S.; Prado, M.M.; Carrizo T.R.; Relationship between Plasma Endothelin-1 and Glycemic Control in Type 2 Diabetes Mellitus; Georg Thieme Verlag Kg; Hormone and Metabolic Research; 33; 12; 12-2001; 748-7510018-5043CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1055/s-2001-19137info:eu-repo/semantics/altIdentifier/url/https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-2001-19137info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:17:57Zoai:ri.conicet.gov.ar:11336/97944instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:17:57.382CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Relationship between Plasma Endothelin-1 and Glycemic Control in Type 2 Diabetes Mellitus |
title |
Relationship between Plasma Endothelin-1 and Glycemic Control in Type 2 Diabetes Mellitus |
spellingShingle |
Relationship between Plasma Endothelin-1 and Glycemic Control in Type 2 Diabetes Mellitus Sanchez, Sara Serafina del V. endothelin-1 diabetes |
title_short |
Relationship between Plasma Endothelin-1 and Glycemic Control in Type 2 Diabetes Mellitus |
title_full |
Relationship between Plasma Endothelin-1 and Glycemic Control in Type 2 Diabetes Mellitus |
title_fullStr |
Relationship between Plasma Endothelin-1 and Glycemic Control in Type 2 Diabetes Mellitus |
title_full_unstemmed |
Relationship between Plasma Endothelin-1 and Glycemic Control in Type 2 Diabetes Mellitus |
title_sort |
Relationship between Plasma Endothelin-1 and Glycemic Control in Type 2 Diabetes Mellitus |
dc.creator.none.fl_str_mv |
Sanchez, Sara Serafina del V. Aybar, Manuel Javier Velarde, M.S. Prado, M.M. Carrizo T.R. |
author |
Sanchez, Sara Serafina del V. |
author_facet |
Sanchez, Sara Serafina del V. Aybar, Manuel Javier Velarde, M.S. Prado, M.M. Carrizo T.R. |
author_role |
author |
author2 |
Aybar, Manuel Javier Velarde, M.S. Prado, M.M. Carrizo T.R. |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
endothelin-1 diabetes |
topic |
endothelin-1 diabetes |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
The pathogenesis of the vascular complications of diabetes is controversial, micro- and macroangiopathy being the most common cause of morbidity and mortality in diabetic patients. Endothelial cell damage, thought to occur in diabetic patients, may be an important factor in development of angiopathy . For the last few years, considerable evidence has connected endothelin-1 (ET-1), a strong endothelial-derived vasoconstrictor mitogenic peptide, with various cardiovascular disease states . Plasma ET-1 concentrations were found to be abnormally high in patients with conditions associated with endothelial cell injury, as well as in those with hypertension , congestive heart failure , coronary artery disease, and uremia . Contradictory findings regarding ET-1 levels have been reported in patients suffering from diabetes mellitus . Bertello et al. and Kanno et al. described similar plasma ET-1 levels in both healthy controls and patients with non-insulin-dependent diabetes mellitus (Type 2 diabetes) with and without complications. However, the influence of Type 2 diabetes on plasma endothelin levels was definitely established in patients with advanced atherosclerosis . Recent clinical studies have indicated that the normalization of glycemic control cannot only prevent diabetic microangiopathies, but might possibly avert cardiovascular complications , thus pointing to hyperglycemia as the major causal factor in the development of diabetic vascular complications. Moreover, there are indications that high blood glucose is involved in the pathogenesis of coronary heart disease, being a significant factor in cardiovascular mortality . However, in spite of the significant effects of hyperglycemia, very few studies have dealt with the possible influence of glucose metabolic control on endothelial reactivity in Type 2 diabetic patients. The aims of the present paper were a) to establish the possible relationship between plasma ET-1 levels and Type 2 diabetes by comparing plasma ET-1 concentrations in healthy subjects with those in patients with uncomplicated Type 2 diabetes and b) to determine whether ET-1 levels were related to glucose metabolic control in diabetic patients. Fil: Sanchez, Sara Serafina del V.. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Instituto Superior de Investigaciones Biológicas. Universidad Nacional de Tucumán. Instituto Superior de Investigaciones Biológicas; Argentina Fil: Aybar, Manuel Javier. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Instituto Superior de Investigaciones Biológicas. Universidad Nacional de Tucumán. Instituto Superior de Investigaciones Biológicas; Argentina Fil: Velarde, M.S.. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia; Argentina Fil: Prado, M.M.. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia; Argentina Fil: Carrizo T.R.. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia; Argentina |
description |
The pathogenesis of the vascular complications of diabetes is controversial, micro- and macroangiopathy being the most common cause of morbidity and mortality in diabetic patients. Endothelial cell damage, thought to occur in diabetic patients, may be an important factor in development of angiopathy . For the last few years, considerable evidence has connected endothelin-1 (ET-1), a strong endothelial-derived vasoconstrictor mitogenic peptide, with various cardiovascular disease states . Plasma ET-1 concentrations were found to be abnormally high in patients with conditions associated with endothelial cell injury, as well as in those with hypertension , congestive heart failure , coronary artery disease, and uremia . Contradictory findings regarding ET-1 levels have been reported in patients suffering from diabetes mellitus . Bertello et al. and Kanno et al. described similar plasma ET-1 levels in both healthy controls and patients with non-insulin-dependent diabetes mellitus (Type 2 diabetes) with and without complications. However, the influence of Type 2 diabetes on plasma endothelin levels was definitely established in patients with advanced atherosclerosis . Recent clinical studies have indicated that the normalization of glycemic control cannot only prevent diabetic microangiopathies, but might possibly avert cardiovascular complications , thus pointing to hyperglycemia as the major causal factor in the development of diabetic vascular complications. Moreover, there are indications that high blood glucose is involved in the pathogenesis of coronary heart disease, being a significant factor in cardiovascular mortality . However, in spite of the significant effects of hyperglycemia, very few studies have dealt with the possible influence of glucose metabolic control on endothelial reactivity in Type 2 diabetic patients. The aims of the present paper were a) to establish the possible relationship between plasma ET-1 levels and Type 2 diabetes by comparing plasma ET-1 concentrations in healthy subjects with those in patients with uncomplicated Type 2 diabetes and b) to determine whether ET-1 levels were related to glucose metabolic control in diabetic patients. |
publishDate |
2001 |
dc.date.none.fl_str_mv |
2001-12 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/97944 Sanchez, Sara Serafina del V.; Aybar, Manuel Javier; Velarde, M.S.; Prado, M.M.; Carrizo T.R.; Relationship between Plasma Endothelin-1 and Glycemic Control in Type 2 Diabetes Mellitus; Georg Thieme Verlag Kg; Hormone and Metabolic Research; 33; 12; 12-2001; 748-751 0018-5043 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/97944 |
identifier_str_mv |
Sanchez, Sara Serafina del V.; Aybar, Manuel Javier; Velarde, M.S.; Prado, M.M.; Carrizo T.R.; Relationship between Plasma Endothelin-1 and Glycemic Control in Type 2 Diabetes Mellitus; Georg Thieme Verlag Kg; Hormone and Metabolic Research; 33; 12; 12-2001; 748-751 0018-5043 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1055/s-2001-19137 info:eu-repo/semantics/altIdentifier/url/https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-2001-19137 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Georg Thieme Verlag Kg |
publisher.none.fl_str_mv |
Georg Thieme Verlag Kg |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614137130254336 |
score |
13.070432 |